✦ LIBER ✦

Absence of the ERBB2 kinase domain mutation in lung adenocarcinomas in Korean patients

✍ Scribed by Jong Woo Lee; Young Hwa Soung; Su Young Kim; Won Sang Park; Suk Woo Nam; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee

Publisher: John Wiley and Sons
Year: 2005
Tongue: French
Weight: 62 KB
Volume: 116
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.21113

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatic mutations of the ERBB4 kinase do

Somatic mutations of the ERBB4 kinase domain in human cancers

✍ Young Hwa Soung; Jong Woo Lee; Su Young Kim; Young Pil Wang; Keon Hyun Jo; Seok 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

The EGFR family consists of 4 receptor tyrosine kinases, EGFR (ERBB1), ERBB2 (HER2), ERBB3 (HER3) and ERBB4 (HER4). Recent reports revealed that the kinase domains of both EGFR (ERBB1) and ERBB2 gene were somatically mutated in human cancers, raising the possibility that the other ERBB members posse

Absence of EGFR mutation in the kinase d

Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer

✍ Jong Woo Lee; Young Hwa Soung; Su Young Kim; Won Sang Park; Suk Woo Nam; Jung Yo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 1 views

Novel mutation in the tyrosine kinase do

Novel mutation in the tyrosine kinase domain of FGFR2 in a patient with Pfeiffer syndrome

✍ Andreas Zankl; Gudrun Jaeger; Luisa Bonafé; Eugen Boltshauser; Andrea Superti-Fu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

Dynamic change of T315I BCR-ABL kinase d

Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors

✍ Wan-Seok Kim; Dongho Kim; Dong-Wook Kim; Il-Young Kweon; Soo-Hyun Kim; Hyun-Gyun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 1 views

## Abstract We analysed the dynamic change of imatinib‐resistant mutations in BCR‐ABL kinase domain focusing on T315I mutation during dasatinib or nilotinib therapy. Fifty‐five imatinib‐resistant chronic myeloid leukaemia patients (32 patients with imatinib‐resistant mutations and 23 patients witho

Direct resequencing of the complete ERBB

Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer

✍ Christina I. Zito; David Riches; Julia Kolmakova; Jan Simons; Michael Egholm; Da 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract Gene amplification is among the most common genetic abnormalities that cause cancer. One of the most clinically important gene amplifications in human cancer causes extensive reduplication of __ERBB2__. A variety of cancers also occasionally harbor somatic mutations in __ERBB2__. Gene a

Mutational analysis of the HER2 gene in

Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features

✍ Fiamma Buttitta; Fabio Barassi; Giuseppina Fresu; Lara Felicioni; Antonio Chella 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 232 KB 👁 2 views

## Abstract Activating mutations in the tyrosine kinase domain of the __HER2__ gene have recently been reported in lung adenocarcinomas, mainly in East Asian patients. Our study was devised to evaluate the prevalence and nature of __HER2__ mutations in lung adenocarcinomas from Caucasian patients.